International Clinical Trials

International Clinical Trials is a company that specializes in the latest scientific technologies and their application to the pharmaceutical industry. These technologies possess great sensitivity & specificity that facilitate comparisons of drug effects on psychomotor performance & driving skills.

International Clinical Trials business model is based on partnerships with other pharmaceutical companies that possess non sedating antipsychotic compounds.

There is a strong unmet medical need for medications that are safer for patients who drive motor vehicles & operate machinery.

Commercial returns for non sedating drugs are maximised throughout their whole product life cycle by early clinical trial comparisons with sedating antipsychotic compounds.

Val Schabinsky founded International Clinical Trials in 2005 and has served as director and chairman since incorporation occurred on 24 October 2011.

Previously he worked in various roles in the pharmaceutical industry at Bristol Myers Squibb & Merck. He also pioneered the positions of medical product specialist at Janssen-Cilag & medical communications manager at Pfizer.

Prior to this, he researched the mechanism of acute tolerance to alcohol & obtained four years academic teaching experience in the Department of Pharmacology, University of Sydney.

Val holds a Bachelor of Science and a Master of Science (Pharmacology) degree from the University of Sydney.

Contact US

Val Schabinsky
37 President Road Kellyville NSW Australia 2155
Tel & Fax: +61298361669
Mob: +61404876694
contact@internationalclinicaltrials.com

Directions

View Larger Map